SGD Pharma, global leader in glass pharmaceutical packaging, has published its latest 2023 Corporate Social Responsibility (CSR) Report illustrating the sustainable practices deeply embedded in its business ethos

 On April 18th, SGD Pharma Zhanjiang plant celebrated the renovation of its furnace with a lighting ceremony.

According to the century-old French glass maker tradition, the new furnace was lighted by its godmother.

Philippe Pourquery will join SGD Pharma, global leader in glass pharmaceutical packaging, from May 6, 2024 as Group Financial Officer and member of the Executive Committee, in replacement of Jérôme Brassens. Philippe will be responsible for Finance and IT across the Group.

At the end of January, SGD Pharma, a global leader in glass primary packaging for the pharmaceutical industry, started a two-week trial using 100% hydrogen burners for industrial-scale glass production. The trial, conducted at SGD Pharma’s state-of-the-art Saint-Quentin-Lamotte (SQLM) manufacturing plant in France, was a resounding success and will inform SGD Pharma’s decarbonization roadmap which aims to reduce CO2 emissions from 2020 by 35% in 2030 and by 65% in 2040.

SGD Pharma, a global leader in glass pharmaceutical packaging, has achieved a gold medal in EcoVadis’ 2024 sustainability ratings. Building upon previous years, SGD Pharma’s score of 78 puts the business in the 98^th percentile for manufacturers of glass and glass products.